Chaperone-mediated autophagy degrades mutant p53

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Missense mutations in the TP53 gene are prevalent in human cancers.
• Accumulated mutant p53 proteins actively promote tumor progression and metastasis.
• Targeting mutant p53 degradation presents a potential therapeutic strategy.

Purpose of the Study:

• Investigate mechanisms governing mutant p53 turnover in nonproliferating tumor cells.
• Explore the role of autophagy in mutant p53 degradation.
• Assess the therapeutic potential of modulating mutant p53 levels in dormant cancer cells.

Main Methods:

• Utilized a combination of pharmacological and genetic approaches.
• Employed methods to suppress macroautophagy.
• Investigated lysosome-dependent degradation pathways.

Main Results:

• Suppression of macroautophagy enhanced mutant p53 degradation via chaperone-mediated autophagy.
• Inhibition of macroautophagy led to the depletion of mutant p53 in dormant cancer cells.
• Macroautophagy inhibition sensitized dormant cancer cells to death.

Conclusions:

• Delineated a novel strategy for eliminating tumor cells reliant on mutant p53.
• Demonstrated that activating chaperone-mediated autophagy can reduce mutant p53 levels.
• Identified potential pharmacological approaches to target mutant p53 in quiescent tumor cells.